Ryzodeg Description

Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Overdosage Contraindications Special Precautions Use In Pregnancy & Lactation Adverse Reactions Drug Interactions Caution For Usage Storage Patient Counseling Information MIMS Class ATC Classification Regulatory Classification Presentation/Packing

The information highlighted (if any) are the most recent updates for this brand.

Full Prescribing Info

Description

1 ml solution contains 100 units insulin degludec/insulin aspart* in the ratio 70/30 (equivalent to 2.56 mg insulin degludec and 1.05 mg insulin aspart).
One pre-filled pen contains 300 units of insulin degludec/insulin aspart in 3 ml solution.
*Produced in Saccharomyces cerevisiae by recombinant DNA technology.
Excipients/Inactive Ingredients: Glycerol, metacresol, phenol, sodium chloride, zinc acetate, hydrochloric acid/sodium hydroxide (for pH adjustment) and water for injections.

Manufacturer:

Novo Nordisk

Distributor:

Firma Chun Cheong

DKSH